Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 2 c.3G>A - p.0? Hamartin binding domain - Unknown - NA g.2098619G>A g.2048618G>A - - TSC2_002080 no significant difference in TSC1 signal; TSC2 signals significantly reduced compared to wild-type TSC2 indicating aa change destabilises TSC2 causing accelerated degradation of variant; mean T389/S6K ratio of variant significantly higher than that of wild-type TSC2 and not different from that of pathogenic TSC2 p.R611Q indicating variant was less effective at inhibiting TORC1 PubMed: Hoogeveen-Westerveld, 2013 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 2 c.3G>A r.0? p.0? - - Unknown - pathogenic g.2098619G>A g.2048618G>A Met1? - TSC2_002080 3rd base of initiation codon; DNA change affects initiation codon PubMed: Hoogeveen-Westerveld, 2013 - - Germline - - BtgI-, HaeIII- - - DNA SEQ Blood - TSC - PubMed: Hoogeveen-Westerveld, 2013 TSC suspected in index case; variant inherited from parent; no clinical information available on parent ? - - - - - - - 2 Rosemary Ekong
+?/+? 2 c.3G>A r.0? p.0? Hamartin binding domain - Unknown - likely pathogenic (dominant) g.2098619G>A g.2048618G>A - - TSC2_002080 3rd base of initiation codon; DNA change affects initiation codon - - - SUMMARY record - - BtgI-, HaeIII- - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.